Tags |
|
|
Links |
|
|
Advice Pool - Alzheimer's Disease - 7 stages of Decline
The seven key symptoms that are charted in the FAST evaluation characterize the progression of Alzheimer's disease. This test provides an indication of the level of care th
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
at is required for a person who has Alzheimer's disease. The symptoms range from unimpaired functions to a very severe cognitive decline.
The Functional Assessment Staging
The Functional Assessment Staging
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
est (FAST) scale was developed by Dr. Reisberg and his colleagues. These test revealed that a person with Alzheimer's is in fact regressing to an infantile state.
The term “
The term “
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
etrogenesis” was coined during the study. The term describes the steady decline of a person who has Alzheimer’s from a person who has no cognitive decline to a person who is
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
in essence an infant with no ability to care for themselves.
A brief overview of the basic symptoms of each stage is outlined below:
Stage 1 - The individual tested
A brief overview of the basic symptoms of each stage is outlined below:
Stage 1 - The individual tested
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
hows no difficulties, either subjectively or objectively.
Stage 2 - The individuals shows some very mild decline. They complain of memory deficits and sometimes forg
Stage 2 - The individuals shows some very mild decline. They complain of memory deficits and sometimes forg
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
tting the names of familiar people and places. This might be regarded as a feature of natural aging rather than a progressive disease disorder.
Stage 3 - The patient
Stage 3 - The patient
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
exhibits a marked decline in memory. The Individual shows an inability to function in a demanding job situation. Anxiety from the inability to remember some pertinent inform
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
tion is noticed in an intensive interview.
Stage 4 - This stage is considered mild or early stage Alzheimer's disease. Clear-cut deficiencies in memory as it relat
Stage 4 - This stage is considered mild or early stage Alzheimer's disease. Clear-cut deficiencies in memory as it relat
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
s to current events or recent personal events. Changes in mood and personality may be noted. The individual is unable to perform complex tasks that involve planning and impl
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
menting a simple dinner menu. The decline in ability is noted as substantial when the person cannot perform mental arithmetic.
Stage 5 - Represents a moderate to sev
Stage 5 - Represents a moderate to sev
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
re decline in cognitive functions. There are some major problems with dates and time. Individual requires assistance performing daily activities. Individuals at this stage
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
are unable to recall important but familiar details. An example is these individuals cannot recall their own address or telephone number. Confusion is present.
The indivi
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ual is able to eat and use the toilet on their own.
Stage 6 - There is a severe cognitive decline at this stage. Difficulties with memory become worse. Personality c
Stage 6 - There is a severe cognitive decline at this stage. Difficulties with memory become worse. Personality c
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
hanges occur. Intensive care is required at this stage for help with basic daily activities. The person is unable to bathe properly. In some cases the individual may develo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
fear of bathing.
Stage 7 - Represents the most severe or late stage Alzheimer's disease. At this stage individuals lose the ability to interact with their environme
Stage 7 - Represents the most severe or late stage Alzheimer's disease. At this stage individuals lose the ability to interact with their environme
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
t. Individuals are unable to speak or control motor movement. These individuals need help with eating, toileting and daily hygiene.
Additional indicators include: Inability
Additional indicators include: Inability
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
to walk without assistance. There is a steady decline in the ability to sit without support. Individuals at this stage are unable to smile or hold up their head. Motor ref
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
exes are abnormal.
The FAST test presents a clinical diagnosis. The confirmation of Alzheimer's disease can only be done by an examination of brain tissue. This is done at
The FAST test presents a clinical diagnosis. The confirmation of Alzheimer's disease can only be done by an examination of brain tissue. This is done at
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
autopsy. The FAST test is used as a guide to provide an overview of the stages of cognitive decline.
================================================================
================================================================
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/241796/advicepool-Alzheimers--Disease--7-stages-of-Decline.html">Alzheimer's Disease - 7 stages of Decline</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/241796/advicepool-Alzheimers--Disease--7-stages-of-Decline.html]Alzheimer's Disease - 7 stages of Decline[/url]
Related Articles:
Empowerism - Why All the Buzz?
Article Marketing Tutorial - Part I
Bookmark it:
|